Article Information
Hannah Joseph Hospital IPO Day 1: Issue subscribed 17% so far. Check GMP, issue details, more
Hannah Joseph Hospital IPO started on January 22 and ends on January 27, with a price band of ₹67-70 per share. Investors can bid for a minimum of 2,000 shares. The hospital focuses on various specialties and aims to use IPO proceeds to enhance services.
markets 2026-01-22 09:44
View OriginalStock Symbol
Entero Healthcare Solutions Li
Sentiment
N/A
Confidence Score
N/A
Full Analysis (JSON)
{
"analysis": {
"input_data": {
"article": "Title: Hannah Joseph Hospital IPO Day 1: Issue subscribed 17% so far. Check GMP, issue details, more\n\nPublished: 2026-01-22\n\nContent: Hannah Joseph Hospital IPO started on January 22 and ends on January 27, with a price band of \u20b967-70 per share. Investors can bid for a minimum of 2,000 shares. The hospital focuses on various specialties and aims to use IPO proceeds to enhance services.",
"full_prompt_sent_to_llm": "=== NEWS ARTICLE ===\nTitle: Hannah Joseph Hospital IPO Day 1: Issue subscribed 17% so far. Check GMP, issue details, more\n\nPublished: 2026-01-22\n\nContent: Hannah Joseph Hospital IPO started on January 22 and ends on January 27, with a price band of \u20b967-70 per share. Investors can bid for a minimum of 2,000 shares. The hospital focuses on various specialties and aims to use IPO proceeds to enhance services.\n\n=== TOP MATCHING STOCK FROM RAG ===\n\nSymbol: ENTERO.NS\nCompany: Entero Healthcare Solutions Limited\nSector: Healthcare\nIndustry: Medical Distribution\nSimilarity Score: 0.3015 (30.15%)\n\nMarket Data:\n\u2022 Current Price: 1108.30\n\u2022 Previous Close: 1123.3\n\u2022 Day Low: 1098.0\n\u2022 Day High: 1128.5\n\u2022 52-Week Low: 1044.9\n\u2022 52-Week High: 1584.25\n\u2022 Volume: 71130\n\u2022 Avg Volume: 103787\n\nAdvanced Technical Indicators (21 total):\nClose_3d:1105.50,1123.30,1108.30 | RSI:46.46 | MACD:-11.330/-15.706/4.375 | BB:1139.91/1104.10/1068.30 | MA:1104.10/1154.11 | ATR:34.15 | OBV:-1,632,539 | WillR:-39.10 | CMF:0.1207 | Ichi:1110.25/1112.40/1111.33/1176.35 | PSAR:1089.02 | Aroon:12.00/56.00 | VWAP:1201.54 | Force:149810.87 | Mass:23.82 | Coppock:0.97 | UltOsc:51.66\n\nQuantitative Risk \u0026 Performance Metrics (35 total):\nAvgVol:79,586 | Price:1108.30 | VaR:-0.0336/-0.0616 | CVaR:-0.0487/-0.0763 | Std:0.0242 | AnnVol:0.3847 | DownDev:0.0228 | Skew:0.7749 | Kurt:5.3823 | Sharpe:-0.4654 | MaxDD:-0.3103 | VolRat:2.5646 | P/MA20:1.0038 | P/MA50:0.9603 | VolReg:0.8620 | Mom:-0.0130/-0.0751 | MeanRet:-0.0007 | W/L:0.91 | Amihud:0.000000 | Roll:0.000000 | VolSurp:-0.4780 | Omega:0.9305 | Sortino:-0.4523 | TailR:1.1116 | ESRat:1.4492 | Hurst:0.1997 | HalfL:20.24 | Mom120:-0.1417 | ApEn:0.7731\n\n=== ANALYZE THE ARTICLE (use RAG context if relevant) ===",
"rag_context": {
"company": "Entero Healthcare Solutions Limited",
"country": "India",
"description_preview": "[STOCK SYMBOL]: ENTERO.NS\n[COMPANY NAME]: Entero Healthcare Solutions Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Medical Distribution\n[COUNTRY]: India\n---------------------------------------------------...",
"full_description": "[STOCK SYMBOL]: ENTERO.NS\n[COMPANY NAME]: Entero Healthcare Solutions Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Medical Distribution\n[COUNTRY]: India\n--------------------------------------------------------------------------------\ncountry - India\nindustry - Medical Distribution\nsector - Healthcare\nlongBusinessSummary - Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.\nfullTimeEmployees - 4111\npreviousClose - 1123.3\nopen - 1125.0\ndayLow - 1098.0\ndayHigh - 1128.5\nregularMarketDayLow - 1098.0\nregularMarketDayHigh - 1128.5\npayoutRatio - 0.0\ntrailingPE - 47.201878\nvolume - 71130\nregularMarketVolume - 71130\naverageVolume - 103787\naverageVolume10days - 84302\naverageDailyVolume10Day - 84302\nmarketCap - 48220925952\nfiftyTwoWeekLow - 1044.9\nfiftyTwoWeekHigh - 1584.25\npriceToSalesTrailing12Months - 0.8925565\nfiftyDayAverage - 1156.156\ntwoHundredDayAverage - 1243.737\ntrailingAnnualDividendRate - 0.0\ntrailingAnnualDividendYield - 0.0\ncurrency - INR\nenterpriseValue - 50002583552\nforwardPE - 21.665527\nprofitMargins - 0.01898\nfloatShares - 11241411\nsharesOutstanding - 43508907\nheldPercentInsiders - 0.62915003\nheldPercentInstitutions - 0.20401\nbookValue - 396.702\npriceToBook - 2.7937849\nearningsQuarterlyGrowth - 0.384\nnetIncomeToCommon - 1025390016\ntrailingEps - 23.48\nenterpriseToRevenue - 0.926\nenterpriseToEbitda - 25.667\nquoteType - EQUITY\ncurrentPrice - 1108.3\ntargetHighPrice - 1590.0\ntargetLowPrice - 1350.0\ntargetMeanPrice - 1497.0\ntargetMedianPrice - 1524.0\nrecommendationMean - 1.5\nrecommendationKey - strong_buy\nnumberOfAnalystOpinions - 4\ntotalCash - 3179760128\ntotalCashPerShare - 73.091\nebitda - 1948120064\ntotalDebt - 3852290048\ntotalRevenue - 54025629696\ndebtToEquity - 21.76\nrevenuePerShare - 1241.809\ngrossProfits - 5259089920\nearningsGrowth - 0.381\nrevenueGrowth - 0.28\ngrossMargins - 0.09734\nebitdaMargins - 0.036059998\noperatingMargins - 0.02935\nregularMarketPrice - 1108.3\nlongName - Entero Healthcare Solutions Limited\nshortName - ENTERO HEALTHCARE SOLU L\nepsTrailingTwelveMonths - 23.48\nepsCurrentYear - 37.545\nexchange - NSI\ntrailingPegRatio - None\n--------------------------------------------------------------------------------\n[BUSINESS SUMMARY]\nEntero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.\n--------------------------------------------------------------------------------\n[IMPORTANT METRICS]\nCompany: Entero Healthcare Solutions Limited\nSector: Healthcare\nIndustry: Medical Distribution\nCountry: India\nMarket Cap: 48.22B\nCurrent Price: 1108.3\nP/E Ratio: 47.201878\nP/B Ratio: 2.7937849\nProfit Margin: 0.0190\nVolume: 71,130\nAvg Volume: 103,787\nDay Range: 1098.0 - 1128.5\n52Wk Range: 1044.9 - 1584.25\nTotal Revenue: 54025629696\nTotal Cash: 3.18B\nTotal Debt: 3.85B\nDebt to Equity: 21.76\nTarget Price: 1350.0 - 1590.0\nAnalyst Opinions: 4\nRecommendation: strong_buy\n--------------------------------------------------------------------------------\n[TECHNICAL] Close_3d:1105.50,1123.30,1108.30 | RSI:46.46 | MACD:-11.330/-15.706/4.375 | BB:1139.91/1104.10/1068.30 | MA:1104.10/1154.11 | ATR:34.15 | OBV:-1,632,539 | WillR:-39.10 | CMF:0.1207 | Ichi:1110.25/1112.40/1111.33/1176.35 | PSAR:1089.02 | Aroon:12.00/56.00 | VWAP:1201.54 | Force:149810.87 | Mass:23.82 | Coppock:0.97 | UltOsc:51.66\n--------------------------------------------------------------------------------\n[QUANT] AvgVol:79,586 | Price:1108.30 | VaR:-0.0336/-0.0616 | CVaR:-0.0487/-0.0763 | Std:0.0242 | AnnVol:0.3847 | DownDev:0.0228 | Skew:0.7749 | Kurt:5.3823 | Sharpe:-0.4654 | MaxDD:-0.3103 | VolRat:2.5646 | P/MA20:1.0038 | P/MA50:0.9603 | VolReg:0.8620 | Mom:-0.0130/-0.0751 | MeanRet:-0.0007 | W/L:0.91 | Amihud:0.000000 | Roll:0.000000 | VolSurp:-0.4780 | Omega:0.9305 | Sortino:-0.4523 | TailR:1.1116 | ESRat:1.4492 | Hurst:0.1997 | HalfL:20.24 | Mom120:-0.1417 | ApEn:0.7731",
"industry": "Medical Distribution",
"sector": "Healthcare",
"similarity_score": 0.301509857,
"symbol": "ENTERO.NS"
}
},
"llm_analysis": {
"actionable_summary": {
"action": "watch",
"bias": "neutral",
"headline": "Hannah Joseph Hospital IPO sees muted day-1 demand",
"rationale": "Wait for final subscription and listing price action"
},
"between_lines": "Market indifferent to small hospital chain IPO",
"confidence_score": 75,
"connections": {
"affects_directly": [
"Hannah Joseph Hospital"
],
"affects_indirectly": [
"healthcare IPO pipeline"
],
"cause_effect_chain": "Low subscription \u2192 potential price-band cut or extended timeline \u2192 sector IPO sentiment",
"follow_the_money": "proceeds earmarked for service expansion"
},
"core": {
"action": "ipo",
"momentum": "neutral",
"momentum_reasoning": "Low initial subscription indicates tepid retail interest",
"sector": "Healthcare",
"topic": "IPO subscription update",
"trigger": "Day-1 subscription at 17%"
},
"cross_stock_impact": [],
"data_quality": {
"article_length_tokens": 65,
"has_financial_data": false,
"has_price_data": true,
"has_sentiment_indicators": false,
"missing_critical_info": [
"GMP",
"anchor allocation",
"company financials",
"IPO size"
],
"overall_quality_score": 0.4
},
"deals": {
"counterparty": [],
"deal_currency": "INR",
"deal_size": null,
"deal_type": "ipo"
},
"entities": [
{
"name": "Hannah Joseph Hospital",
"role": "issuer",
"ticker": null,
"type": "company"
}
],
"financials": {
"buyback": null,
"data_source": "null",
"dividend": null,
"funding_amount": null,
"guidance": null,
"profit": null,
"revenue": null,
"valuation": null
},
"market_reaction": {
"expected_impact": "Neutral; micro-cap hospital IPO has limited index weight",
"index_impact": [],
"price_change": null,
"volume_change": null
},
"numerical_extractions": {
"fiscal_period": null,
"mentioned_prices": [
"\u20b967",
"\u20b970"
],
"mentioned_targets": [],
"poll_source": null,
"profit_change_pct": null,
"revenue_change_pct": null,
"volume_growth_yoy_pct": null
},
"patterns": {
"pattern_reasoning": "Early-stage IPO with below-average subscription",
"pattern_type": "ipo",
"similar_past_event": null,
"stage": "early",
"strength": "weak"
},
"rag_alignment": {
"rag_company_relevant": "no",
"relevance_reasoning": "RAG similarity only 30.15%; Entero Healthcare is a distributor while Hannah Joseph is a hospital operator\u2014different business models",
"should_prioritize_rag": false,
"similarity_interpretation": "weak_connection"
},
"reasoning_chain": [
"IPO opens 22 Jan",
"17% subscribed by day 1",
"Price band \u20b967-70",
"No premium or anchor data",
"Weak retail interest"
],
"red_flags": [
"No GMP data",
"No anchor book details",
"Low day-1 subscription"
],
"sentiment": {
"confidence": 0.8,
"direction": "neutral",
"drivers": [
"17% subscription on day 1",
"no price premium mentioned",
"no anchor interest disclosed"
],
"intensity": 0.3
},
"signals": {
"crowd_behavior": {
"source": "inference",
"value": "apathy"
},
"key_levels": {
"source": "article",
"values": [
"\u20b967",
"\u20b970"
]
},
"price_action_expected": {
"source": "inference",
"value": "range"
},
"reaction_reasoning": "Low subscription shows weak retail interest; GMP not mentioned implies no grey-market premium",
"volume_expectation": {
"source": "inference",
"value": "normal"
}
},
"smart_money": {
"big_players": [],
"evidence": "Low day-1 subscription",
"retail_position": "neutral",
"their_likely_motive": "waiting for retail appetite"
},
"timing": {
"catalyst_date": "2026-01-27",
"expected_duration_days": 5,
"temporal_anchor": "2026-01-22",
"urgency": "this_week"
},
"trading_angles": [
{
"conviction": "high",
"idea": "Avoid until final subscription numbers",
"reasoning": "17% day-1 is well below recent healthcare IPO averages",
"risk": "IPO may undersubscribe and list flat"
}
]
},
"metrics": {
"model_params": {
"max_completion_tokens": 8192,
"model": "moonshotai/kimi-k2-instruct-0905",
"reasoning_effort": "medium",
"stream": false,
"temperature": 0.4,
"top_p": 0.9
},
"timing": {
"end_time": "2026-01-22T09:53:17.762895",
"llm_response_seconds": 3.11,
"rag_query_seconds": 0.681,
"start_time": "2026-01-22T09:53:13.969789",
"total_duration_seconds": 3.793
},
"tokens": {
"actual_from_api": {
"input_tokens": 4679,
"output_tokens": 962,
"total_tokens": 5641
}
}
},
"rag_match": {
"company": "Entero Healthcare Solutions Limited",
"sector": "Healthcare",
"similarity_score": 0.301509857,
"symbol": "ENTERO.NS"
},
"timestamp": "2026-01-22T09:53:17.763206"
},
"article_id": "f8a49465-4a3b-4c25-9839-37ac54b27d0c",
"result_id": "20260122_095317",
"status": "completed"
}
Key Insights